Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05826041 · ClinicalTrials.gov registry record · NA

Project INSPIRE: INtervention Support Groups: Peers Inspiring Resilience and Empowerment

A NA study, sponsored by Yale University.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT05826041: Clinical Trial NA study, sponsored by Yale University.

NCT05826041 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05826041, a NA study, was terminated before completion, sponsored by Yale University.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

The investigators will develop a new, integrated, group intervention to enhance safety, support, and empowerment for survivors of intimate partner violence in the community. The intervention will consist of 9 weekly, 90-minute group sessions that will teach specific skills for identifying various forms of trauma and abuse, developing mutually supportive relationships, safety planning and self-care, goal-oriented communication, empowerment and self-efficacy, goal setting, coping, and connecting to resources. The investigators will pilot test the intervention, including evaluating the process of implementation, including feasibility, acceptability/likeability, and safety, as well as evaluating outcomes of safety, support, and empowerment. Outcomes from the intervention will be compared to outcomes from a traditional domestic violence support group.

Primary Outcome

Group cohesion will be assessed weekly by a modified version of the GAS. The 20 items are rated on a 1-5 Likert scale. A total score is computed by averaging the items. Scores range from 1-5, with higher scores indicating more group cohesion.

Interventions

  • BEHAVIORAL (INSPIRE) INtervention Support groups: Peers Inspiring Resilience and Empowerment.
  • BEHAVIORAL Traditional Domestic Violence Support Group

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2023-03-23
Est. Completion 2023-11-28
Phase NA
Yale University

1,492 total trials

Why NCT05826041 stopped before completion

NCT05826041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which (INSPIRE) INtervention Support groups: Peers Inspiring Resilience and Empowerment. is the first listed.

NCT05826041 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05826041 about?

NCT05826041 is a clinical study titled "Project INSPIRE: INtervention Support Groups: Peers Inspiring Resilience and Empowerment". The investigators will develop a new, integrated, group intervention to enhance safety, support, and empowerment for survivors of intimate partner violence in the community. The intervention will consist of 9 weekly, 90-minute group sessions that will teach specific skills for identifying various fo...

What is the current status of trial NCT05826041?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2023-03-23. Estimated completion is 2023-11-28.

What interventions are being tested in trial NCT05826041?

The interventions under investigation include: (INSPIRE) INtervention Support groups: Peers Inspiring Resilience and Empowerment. (BEHAVIORAL), Traditional Domestic Violence Support Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT05826041?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05826041's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05826041, the US trial registry maintained by the National Library of Medicine. NCT05826041 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.